Related references
Note: Only part of the references are listed.Porcine recombinant factor VIII (Obizur; OBI-1; BAX801): product characteristics and preclinical profile
D. Lillicrap et al.
HAEMOPHILIA (2016)
Safety of PEGylated recombinant human full-length coagulation factor VIII (BAX 855) in the overall context of PEG and PEG conjugates
R. Stidl et al.
HAEMOPHILIA (2016)
Discrepancies between one stage assay and chromogenic substrate assay in patients treated with recombinant or plasma-derived FVIII and usefulness of a specific standard in ReFacto AF®-treated patients
C. Pouplard et al.
HAEMOPHILIA (2016)
BAY 81-8973, a full-length recombinant factor VIII: results from an International comparative laboratory field study
S. Kitchen et al.
HAEMOPHILIA (2016)
A computer-based model to assess costs associated with the use of factor VIII and factor IX one-stage and chromogenic activity assays
S. Kitchen et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)
A critical appraisal of one-stage and chromogenic assays of factor VIII activity
F. Peyvandi et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)
Development, Validation, and Application of a Novel Ligand-Binding Assay to Selectively Measure PEGylated Recombinant Human Coagulation Factor VIII (BAX 855)
Alfred Weber et al.
BIOCONJUGATE CHEMISTRY (2015)
One-stage vs. chromogenic assays in haemophilia A
Joachim J. Potgieter et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2015)
Efficacy and safety of OBI-1, an antihaemophilic factor VIII (recombinant), porcine sequence, in subjects with acquired haemophilia A
R. Kruse-Jarres et al.
HAEMOPHILIA (2015)
Current laboratory practices in the diagnosis and management of haemophilia: a global assessment
S. Kitchen et al.
HAEMOPHILIA (2015)
The biological efficacy profile of BAX 855, a PEGylated recombinant factor VIII molecule
L. A. Valentino et al.
HAEMOPHILIA (2015)
Comparative field study evaluating the activity of recombinant factor VIII Fc fusion protein in plasma samples at clinical haemostasis laboratories
J. M. Sommer et al.
HAEMOPHILIA (2014)
Monitoring of modified factor VIII and IX products
S. Kitchen et al.
HAEMOPHILIA (2014)
Evaluation of the activated partial thromboplastin time assay for clinical monitoring of PEGylated recombinant factor VIII (BAY 94-9027) for haemophilia A
J-M. Gu et al.
HAEMOPHILIA (2014)
Comparative field study: impact of laboratory assay variability on the assessment of recombinant factor IX Fc fusion protein (rFIXFc) activity
Jurg M. Sommer et al.
THROMBOSIS AND HAEMOSTASIS (2014)
Recommendations on the potency labelling of factor VIII and factor IX concentrates
A. R. Hubbard et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2013)
New cell line development for antibody-producing Chinese hamster ovary cells using split green fluorescent protein
Yeon-Gu Kim et al.
BMC BIOTECHNOLOGY (2012)
Pharmacokinetics and safety of OBI-1, a recombinant B domain-deleted porcine factor VIII, in subjects with haemophilia A
C. L. Kempton et al.
HAEMOPHILIA (2012)
International comparative field study of N8 evaluating factor VIII assay performance
D. Viuff et al.
HAEMOPHILIA (2011)
Performance of recalibrated ReFacto® laboratory standard in the measurement of FVIII plasma concentration via the chromogenic and one-stage assays after infusion of recalibrated ReFacto® (B-domain deleted recombinant factor VIII)
C. Santoro et al.
HAEMOPHILIA (2009)
The between-Laboratory Variation of Factor VIII Inhibitor Testing: The Experience of the External Quality Assessment Program of the ECAT Foundation
Piet Meijer et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2009)
Interlaboratory Variation in Factor VIII:C Inhibitor Assay Results Is Sufficient to Influence Patient Management: Data from the UK National Quality External Assessment Scheme for Blood Coagulation
Steve Kitchen et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2009)
The protein structure and effect of factor VIII
Hong Fang et al.
THROMBOSIS RESEARCH (2007)
Factor VIII and thrombin generation assays: relevance to pharmacokinetic studies in haemophilia A
T. W. Barrowcliffe
HAEMOPHILIA (2006)
New approaches for measuring coagulation
TW Barrowcliffe et al.
HAEMOPHILIA (2006)
Factor VIII structure and function
PJ Fay
INTERNATIONAL JOURNAL OF HEMATOLOGY (2006)
Coagulation and chromogenic assays of factor VIII activity: General aspects, standardization, and recommendations
TW Barrowcliffe et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2002)
Share Paper
